ACS CAN Calls for Harmonizing and Modernizing Regulatory Framework for Diagnostic Tests
WASHINGTON, D.C. –Today, the American Cancer Society Cancer Action Network submitted a statement for the record to the House Energy & Commerce Committee Health Subcommittee in regards to their hearing on Evaluating Approaches to Diagnostic Test Regulation and the impact of the FDA’s proposed rule. The statement reads in part:
“Our preference is for Congress to pass legislation to modernize and harmonize diagnostics oversight, and we have supported the Verifying Accurate, Leading-edge IVCT Development (VALID) Act as a way to achieve that reform. However, until legislation is passed, we believe that taking a regulatory approach to harmonization is appropriate. We encourage Congress to move forward with legislation and look forward to working with you.”
Read the full statement here.